New drugs approved to fight idiopathic pulmonary fibrosis

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

Gene regulators of circulating trans fatty acids identified

High consumption of trans fatty acids (TFA) has been linked to increased risk of heart disease, stroke and even cancer.

Vanderbilt University Medical Center offers surgical option for form of pulmonary hypertension

VUSM students land Sarnoff Foundation awards

Two Vanderbilt University School of Medicine students are among 11 individuals nationwide to receive Sarnoff Foundation Medical Student Research Fellowship awards for 2014-2015.

NIH grant spurs diabetic nephropathy research

Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

Heart patient uses ICD experience to promote benefits of exercise

Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA).